Georgia's Online Cancer Information Center

Find A Treatment Site

Piedmont Columbus Regional

The John B. Amos Cancer Center is a multi-disciplinary cancer center accredited by the Commission on Cancer of the American College of Surgeons as a Community Hospital Comprehensive Cancer Program – the only treatment center to be so named in the 14-county service area of Columbus, Georgia. The center is also accredited by the American College of Radiology (ACR). The John B. Amos Cancer Center is a recipient of the Georgia Cancer Coalition Distinguished Cancer Scholars Award, which supports leaders who are engaged in the most promising areas of cancer research. John B. Amos is a member of the Atlanta Regional Community Clinical Oncology Program (ARCCOP), a program initiated by the National Cancer Institute (NCI) to provide community hospitals access to a wide range of clinical research studies. The center is also a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers and a member of the Georgia CORE Gynecologic Oncology Group Consortium. The center consists of eleven physicians with three clinics: medical oncology, gynecologic oncology and radiation oncology. The John B. Amos Cancer Center offers a medical team of experienced board-certified oncologists (MDs), advanced registered nurse practitioners, clinical researchers, case manager associates, clinical counselors, pharmacists, radiation physicists and therapists, oncology- and chemotherapy-certified nurses and registered dietitians.

Treatment Sites in Georgia

Clinical Trials in Georgia

Connect® Myeloid Disease Registry
Cancer Type: Cancer-Related Syndrome, Leukemia, Myelodysplastic Syndromes (MDS)
Study Coordinator: Jay Pitts, BS, CPhT - 706-596-5426


Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Cancer Type: Lung Cancer
Study Coordinator: Jay Pitts, BS, CPhT - 706-596-5426


Eflornithine and/or Sulindac in Preventing Recurrence of High-Risk Adenomas and Second Primary Disease in Patients with Stage 0-III Colon or Rectal Cancer
Cancer Type: Colon/Rectal Cancer, Unknown Primary
Study Coordinator: Jay Pitts, BS, CPhT - 706-596-5426


Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer

Targeted Therapy Directed by Genetic Testing in Treating Patients with Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Cancer Type: Bladder Cancer, Brain & Spinal Cord Tumor, Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer / Hepatoblastoma, Lung Cancer, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Cancer, Pancreatic Cancer, Plasma cell neoplasm, Prostate Cancer , Skin Cancer (Non-Melanoma), Stomach/ Gastric Cancer, Thyroid Cancer, Unknown Primary, Uterine Cancer
Study Coordinator: Jay Pitts, BS, CPhT - 706-596-5426
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.